Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 3/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.45 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29286402 | 0.87 | NFE2L2 (0.49) | NFE2L2KDM4EHPGDLMNACA12 | |
| SCHEMBL1954243 | 0.87 | CA12 (0.54) | NFE2L2KDM4EHPGDLMNACA12 | |
| SCHEMBL2160012 | 0.86 | NFE2L2 (0.54) | NFE2L2KDM4EHPGDLMNACA12 | |
| SCHEMBL6963260 | 0.86 | NFE2L2 (0.54) | NFE2L2KDM4EHPGDLMNACA12 | |
| SCHEMBL3327023 | 0.86 | MAPK1 (0.58) | NFE2L2KDM4EHPGDLMNACA12 | |
| SCHEMBL3624482 | 0.84 | NFE2L2 (0.53) | NFE2L2KDM4EHPGDLMNACA12 | |
| SCHEMBL25304559 | 0.83 | NFE2L2 (0.53) | NFE2L2KDM4EHPGDLMNACA12 | |
| SCHEMBL29286399 | 0.82 | NFE2L2 (0.49) | NFE2L2KDM4EHPGDLMNACYP1A1 | |
| SCHEMBL25434306 | 0.82 | CA1 (0.61) | NFE2L2KDM4EHPGDLMNACA12 | |
| SCHEMBL151213 | 0.82 | CA1 (0.61) | NFE2L2KDM4EHPGDLMNACA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5527875-A | Process for producing aromatic polycarbonate | MITSUBISHI CHEMICAL CORPORATION (JP) | 1996-06-18 | — | — | US | claimed |
| US-10377847-B2 | Strong reversible hydrogels | SUPRAPOLIX B.V. (NL) | 2019-08-13 | — | — | US | disclosed |
| EP-2343342-B1 | STRONG REVERSIBLE HYDROGELS | SUPRAPOLIX BV (NL) | 2015-09-16 | — | — | EP | disclosed |
| US-20140128482-A1 | STRONG REVERSIBLE HYDROGELS | SUPRAPOLIX B.V. (NL) | 2014-05-08 | — | — | US | disclosed |
| US-8628789-B2 | Strong reversible hydrogels | SUPRAPOLIX, B.V. (NL) | 2014-01-14 | — | — | US | disclosed |
| EP-2343342-A1 | Strong reversible hydrogels | SupraPolix B.V. (NL) | 2011-07-13 | — | — | EP | disclosed |
| EP-1972661-B1 | Strong reversible hydrogels | SUPRAPOLIX BV (NL) | 2011-07-06 | — | — | EP | disclosed |
| US-20080260795-A1 | STRONG REVERSIBLE HYDROGELS | SUPRAPOLIX B.V. | 2008-10-23 | — | — | US | disclosed |
| EP-1972661-A1 | Strong reversible hydrogels | SupraPolix B.V. (NL) | 2008-09-24 | — | — | EP | disclosed |
| EP-0703262-B1 | Process for producing aromatic polycarbonate | MITSUBISHI CHEM CORP (JP) | 1999-12-15 | — | — | EP | disclosed |
| EP-0673959-B1 | Process for producing aromatic polycarbonate | MITSUBISHI CHEM CORP (JP) | 1998-10-28 | — | — | EP | disclosed |
| US-5578694-A | MELT POLYCONDENSATION OF AROMATIC DIOL AND DIARYL CARBONATE; ESTER INTERCHANGE USING PHOSPHONIUM CATALYST | MITSUBISHI CHEMICAL CORPORATION (JP) | 1996-11-26 | — | — | US | disclosed |
| US-5527875-A | Process for producing aromatic polycarbonate | MITSUBISHI CHEMICAL CORPORATION (JP) | 1996-06-18 | — | — | US | disclosed |
| EP-0703262-A2 | Process for producing aromatic polycarbonate | Mitsubishi Chemical Corporation (JP) | 1996-03-27 | — | — | EP | disclosed |
| EP-0673959-A1 | Process for producing aromatic polycarbonate | Mitsubishi Chemical Corporation (JP) | 1995-09-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10377847-B2 | Strong reversible hydrogels | HSPA4L, H1-4, CD44 | NFE2L2 3034/4885KDM4E 934/4885HPGD 185/4885 |
| US-20080260795-A1 | STRONG REVERSIBLE HYDROGELS | HSPA4L, H1-4, CD44 | NFE2L2 3034/4885KDM4E 934/4885HPGD 185/4885 |
| US-20140128482-A1 | STRONG REVERSIBLE HYDROGELS | HSPA4L, H1-4, CD44 | NFE2L2 3034/4885KDM4E 934/4885HPGD 185/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.